Expert Opinion on Emerging Drugs
Volume 28, 2023 - Issue 2
Open access
2,477
Views
0
CrossRef citations to date
0
Altmetric
Review
Emerging peptide therapeutics for the treatment of ovarian cancer
Ana C. Veneziania Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canadahttps://orcid.org/0000-0003-3980-034XView further author information
, Eduardo Gonzalez-Ochoaa Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canadahttps://orcid.org/0000-0002-1056-5967View further author information
& Amit M. Ozaa Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada;b Department of Medicine, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-9510-8641View further author information
https://orcid.org/0000-0002-9510-8641View further author information
Pages 129-144
|
Received 15 Mar 2023, Accepted 23 May 2023, Published online: 07 Jun 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.